Bio-Rad Laboratories (BIO) News Today $358.19 +27.61 (+8.35%) (As of 10/31/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Bio-Rad Reports Third-Quarter 2024 Financial ResultsOctober 31 at 12:11 PM | finance.yahoo.comBio-Rad price target raised to $450 from $400 at CitiOctober 31 at 12:11 PM | markets.businessinsider.comRBC Capital Sticks to Their Buy Rating for Bio-Rad Laboratories (BIO)October 31 at 12:11 PM | markets.businessinsider.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Louisiana State Employees Retirement SystemLouisiana State Employees Retirement System grew its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 341.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 5,300 shares of the medical research company's stock after acquiring an additiOctober 31 at 3:43 AM | marketbeat.comBio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unitOctober 30 at 6:09 PM | reuters.comBio-Rad Laboratories (BIO) Set to Announce Earnings on WednesdayOctober 29 at 5:07 AM | americanbankingnews.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Assenagon Asset Management S.A.Assenagon Asset Management S.A. reduced its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 22.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 41,960 shares of the medOctober 27, 2024 | marketbeat.comBio-Rad Laboratories (BIO) Scheduled to Post Earnings on WednesdayBio-Rad Laboratories (NYSE:BIO) will be releasing earnings after the market closes on Wednesday, October 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=635449)October 23, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC decreased its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 148,722 shares of theOctober 23, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Shares Gap Up - Still a Buy?Bio-Rad Laboratories (NYSE:BIO) Shares Gap Up - Here's WhyOctober 17, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Stock Price Down 2.8% - Here's What HappenedBio-Rad Laboratories (NYSE:BIO) Shares Down 2.8% - What's Next?October 16, 2024 | marketbeat.comBio-Rad Laboratories, Inc. Forecasted to Post Q3 2024 Earnings of $1.28 Per Share (NYSE:BIO)Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Zacks Research issued their Q3 2024 earnings per share (EPS) estimates for Bio-Rad Laboratories in a research note issued to investors on Monday, October 14th. Zacks Research analyst R. Department expects that the medical research company willOctober 16, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Danaher (DHR) and Thermo Fisher (TMO)October 16, 2024 | markets.businessinsider.comBio-Rad Laboratories, Inc. (NYSE:BIO) Forecasted to Earn Q4 2024 Earnings of $2.77 Per ShareBio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Analysts at Zacks Research dropped their Q4 2024 EPS estimates for shares of Bio-Rad Laboratories in a research report issued on Monday, October 14th. Zacks Research analyst R. Department now forecasts that the medical research company will eaOctober 15, 2024 | marketbeat.comBio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024October 14, 2024 | businesswire.comSanctuary Advisors LLC Buys Shares of 2,663 Bio-Rad Laboratories, Inc. (NYSE:BIO)Sanctuary Advisors LLC bought a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,663 shares of the medical research company's stock, valued at approximately $October 14, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Sees Significant Decrease in Short InterestBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) was the recipient of a significant drop in short interest in September. As of September 30th, there was short interest totalling 851,300 shares, a drop of 36.9% from the September 15th total of 1,350,000 shares. Based on an average daily volume of 309,900 shares, the days-to-cover ratio is presently 2.7 days. Approximately 4.5% of the company's stock are sold short.October 12, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Truist Financial CorpTruist Financial Corp trimmed its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 16.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 8,931 shares of the medical research company's stock after selOctober 11, 2024 | marketbeat.comRK Asset Management LLC Makes New $5.20 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)RK Asset Management LLC bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 15,537 shares of the medical research company's stock, valued at approOctober 7, 2024 | marketbeat.comParagon Capital Management Inc. Purchases Shares of 4,793 Bio-Rad Laboratories, Inc. (NYSE:BIO)Paragon Capital Management Inc. acquired a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,793 shares of the medical researOctober 3, 2024 | marketbeat.comCitigroup Upgrades Bio-Rad Laboratories (BIO.B)October 2, 2024 | msn.comCitigroup Upgrades Bio-Rad Laboratories (BIO)October 2, 2024 | msn.comAQR Capital Management LLC Has $13.09 Million Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)AQR Capital Management LLC lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 47,954 shares of the medical research company's stock aOctober 2, 2024 | marketbeat.comAssessment of Western Blotting Markets Through 2030, Featuring Strategic Analysis of Advansta, Bio-Rad Labs, LI-COR, Merck, PerkinElmer & MoreOctober 1, 2024 | finance.yahoo.comExpert Ratings For Bio-Rad LaboratoriesOctober 1, 2024 | benzinga.comWilliam B. Walkup & Associates Inc. Makes New $519,000 Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)William B. Walkup & Associates Inc. bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,902 shares of the medical researchSeptember 30, 2024 | marketbeat.comScientech Research LLC Invests $1.19 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Scientech Research LLC acquired a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 4,343 shares of the medical research company's stock, vSeptember 28, 2024 | marketbeat.comFood Diagnostics Market Overview, Growth Drivers, Key Segments, Latest Trends, Regional Insight, Recent Developments, and Top CompaniesSeptember 27, 2024 | theglobeandmail.comSelect Equity Group L.P. Purchases 134,856 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Select Equity Group L.P. increased its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 26.2% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 649,522 shares of the medical research company's stoSeptember 27, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Earnest Partners LLCEarnest Partners LLC increased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 17.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 606,788 shares of the medical research company's stock after aSeptember 26, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from BrokeragesShares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) have received a consensus rating of "Hold" from the five brokerages that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendationSeptember 25, 2024 | marketbeat.comS&P 500 Shake-Up: New Entrants Driving Market Momentum (BIO)The quarterly rebalancing of the S&P 500 reflects market capitalization and performance shifts, highlighting growth and challenges in multiple sectors.September 24, 2024 | marketbeat.comFrank Rimerman Advisors LLC Acquires New Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Frank Rimerman Advisors LLC purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 2,048 shares of the medical research company's stockSeptember 24, 2024 | marketbeat.comSei Investments Co. Raises Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Sei Investments Co. grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 28.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 240,161 shares of the medical research company's stock afSeptember 23, 2024 | marketbeat.comXTX Topco Ltd Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)XTX Topco Ltd acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,389 shares of the medical research company's stock, valued at approxiSeptember 22, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Shares Down 4.3% Bio-Rad Laboratories (NYSE:BIO) Shares Down 4.3%September 20, 2024 | marketbeat.comIranian Immigrant Becomes Billionaire As Her Biotech Firm’s Stock SoarsSeptember 20, 2024 | forbes.comBio-Rad Laboratories, Inc. (NYSE:BIO) to Post Q3 2024 Earnings of $2.13 Per Share, Zacks Research ForecastsBio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Investment analysts at Zacks Research reduced their Q3 2024 earnings per share (EPS) estimates for shares of Bio-Rad Laboratories in a note issued to investors on Tuesday, September 17th. Zacks Research analyst R. Department now expects that tSeptember 19, 2024 | marketbeat.comFirst Eagle Investment Management LLC Has $173.77 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)First Eagle Investment Management LLC grew its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 32,296.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 636,27September 19, 2024 | marketbeat.comDekaBank Deutsche Girozentrale Purchases 3,252 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)DekaBank Deutsche Girozentrale increased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 26.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,587 shares of the medical research company's stock aSeptember 18, 2024 | marketbeat.comVictory Capital Management Inc. Has $5.77 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Victory Capital Management Inc. raised its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 18.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,108 shares of the medical reSeptember 17, 2024 | marketbeat.comFederated Hermes Inc. Purchases 4,253 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Federated Hermes Inc. lifted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 94,436 shares of the medical research compSeptember 16, 2024 | marketbeat.comThompson Siegel & Walmsley LLC Has $106.52 Million Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Thompson Siegel & Walmsley LLC grew its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 11.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 390,020 shares of the medical research company's sSeptember 15, 2024 | marketbeat.comClinical Chemistry Analyzers Market to Grow by USD 3.33 Billion (2024-2028) with New AI-Driven Launches Boosting Revenue - Technavio ReportSeptember 13, 2024 | finance.yahoo.comTransplant Diagnostics Market Future Opportunities, Business Growth, Share, Global Size, Demand, Key Segments And Forecast To 2028September 13, 2024 | theglobeandmail.comRhumbline Advisers Sells 2,457 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Rhumbline Advisers trimmed its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 6.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,863 shares of the medical research companSeptember 13, 2024 | marketbeat.com3 Analyst-Backed Tech Stocks to Scoop Up Amid the Sector's DipSeptember 11, 2024 | msn.comBio-Rad Laboratories, Inc. (NYSE:BIO) COO Andrew J. Last Sells 3,000 SharesSeptember 11, 2024 | insidertrades.comPrincipal Financial Group Inc. Sells 4,383 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Principal Financial Group Inc. lessened its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 16.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 22,672 shares of the medical research company's stocSeptember 10, 2024 | marketbeat.comCandriam S.C.A. Sells 36,284 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Candriam S.C.A. reduced its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 60.8% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 23,374 shares of the medical research company's stock aSeptember 9, 2024 | marketbeat.com Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address The real reason Elon is fully endorsing Trump (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, BIO Media Mentions By Week BIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼0.750.68▲Average Medical News Sentiment BIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼66▲BIO Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Illumina News Waters News Bio-Techne News Charles River Laboratories International News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
